Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2021

Open Access 01-12-2021 | Fatigue | Research

The relation between EQ-5D and fatigue in a Dutch general population sample: an explorative study

Authors: I. Spronk, S. Polinder, G. J. Bonsel, M. F. Janssen, J. A. Haagsma

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Login to get access

Abstract

Background

Fatigue negatively influences health-related quality of life. It is questionable whether fatigue is sufficiently covered by the EQ-5D. This study investigated whether fatigue is covered by the existing domains of the EQ-5D.

Methods

A Dutch general population sample completed the EQ-5D (3L and 5L version) and the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), of which the fatigue item was used. Outcomes were compared between participants with and without a chronic health condition. Convergent validity was assessed, and multivariate regression analyses was used to predict the RPQ fatigue item from the EQ-5D-3L and EQ-5D-5L domains separately.

Results

3027 people completed the survey, of whom 52% had ≥ 1 chronic health condition. Fatigue was reported by 48% of the participants. Fatigue was moderately correlated to the EQ-5D domains ‘pain/discomfort’, ‘usual activities’, and ‘anxiety/depression’ for the 3L (r = 0.379–0.426) and 5L version (r = 0.411–0.469). For the 5L, also a moderate correlation with ‘mobility’ (r = 0.335) was observed. The remaining correlations were weak. All EQ-5D-3L and 5L domains except for ‘mobility’ were significantly associated with the RPQ fatigue item (unstandardized Beta = − 0.20–0.67; p < 0.01 to p = 0.04). Comparable outcomes were found for participants with and without ≥ 1 chronic health condition.

Conclusions

The extent to which fatigue is covered by the EQ-5D domains is small to moderate, with the EQ-5D-5L being slightly more sensitive to capture fatigue compared to the EQ-5D-3L. An extra fatigue item for the EQ-5D may add value, as fatigue is not fully captured by the existing domains, both in people with and without a chronic health condition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fiteni F, Le Ray I, Ousmen A, Isambert N, Anota A, Bonnetain F. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review. BMC Cancer. 2019;19(1):361.CrossRef Fiteni F, Le Ray I, Ousmen A, Isambert N, Anota A, Bonnetain F. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review. BMC Cancer. 2019;19(1):361.CrossRef
2.
go back to reference Dellenmark-Blom M, Sjöström S, Abrahamsson K, Holmdahl G. Health-related quality of life among children, adolescents, and adults with bladder exstrophy–epispadias complex: a systematic review of the literature and recommendations for future research. Qual Life Res. 2019;28:1–24.CrossRef Dellenmark-Blom M, Sjöström S, Abrahamsson K, Holmdahl G. Health-related quality of life among children, adolescents, and adults with bladder exstrophy–epispadias complex: a systematic review of the literature and recommendations for future research. Qual Life Res. 2019;28:1–24.CrossRef
3.
go back to reference Spronk I, Legemate C, Oen I, van Loey NE, Polinder S, van Baar ME. Health related quality of life in adults after burn injuries: a systematic review. PLoS ONE. 2018;13(5):e0197507.CrossRef Spronk I, Legemate C, Oen I, van Loey NE, Polinder S, van Baar ME. Health related quality of life in adults after burn injuries: a systematic review. PLoS ONE. 2018;13(5):e0197507.CrossRef
4.
go back to reference Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurements in clinical trials: choosing the right approach. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, vol 2; 1996. p. 41–48. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurements in clinical trials: choosing the right approach. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, vol 2; 1996. p. 41–48.
5.
go back to reference Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17(1):13–35.CrossRef Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17(1):13–35.CrossRef
6.
go back to reference Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.CrossRef Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.CrossRef
7.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef
8.
go back to reference Rabin R, Charro FD. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRef Rabin R, Charro FD. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRef
9.
go back to reference Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):vii.CrossRef Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):vii.CrossRef
10.
go back to reference Jelsma J, Maart S. Should additional domains be added to the EQ-5D health-related quality of life instrument for community-based studies? An analytical descriptive study. J Popul Health Metrics. 2015;13(1):13.CrossRef Jelsma J, Maart S. Should additional domains be added to the EQ-5D health-related quality of life instrument for community-based studies? An analytical descriptive study. J Popul Health Metrics. 2015;13(1):13.CrossRef
11.
go back to reference Kaarlola A, Pettilä V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med. 2004;30(12):2245–52.CrossRef Kaarlola A, Pettilä V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med. 2004;30(12):2245–52.CrossRef
12.
go back to reference Finch AP, Brazier JE, Mukuria C. What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews. Eur J Health Econ. 2018;19(4):557–70.CrossRef Finch AP, Brazier JE, Mukuria C. What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews. Eur J Health Econ. 2018;19(4):557–70.CrossRef
13.
go back to reference Swinburn P, Lloyd A, Boye K, Edson-Heredia E, Bowman L, Janssen B. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value Health. 2013;16(8):1156–62.CrossRef Swinburn P, Lloyd A, Boye K, Edson-Heredia E, Bowman L, Janssen B. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value Health. 2013;16(8):1156–62.CrossRef
14.
go back to reference Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM. Relations between sleep, fatigue, and health-related quality of life in individuals with insomnia. J Psychosom Res. 2010;69(5):475–83.CrossRef Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM. Relations between sleep, fatigue, and health-related quality of life in individuals with insomnia. J Psychosom Res. 2010;69(5):475–83.CrossRef
15.
go back to reference Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum. 2004;51(4):578–85.CrossRef Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum. 2004;51(4):578–85.CrossRef
16.
go back to reference Kluthcovsky ACGC, Urbanetz AA, de Carvalho DS, Maluf EMCP, Sylvestre GCS, Hatschbach SBB. Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer. 2012;20(8):1901–9.CrossRef Kluthcovsky ACGC, Urbanetz AA, de Carvalho DS, Maluf EMCP, Sylvestre GCS, Hatschbach SBB. Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer. 2012;20(8):1901–9.CrossRef
17.
go back to reference Gold JI, Mahrer NE, Yee J, Palermo TM. Pain, fatigue and health-related quality of life in children and adolescents with chronic pain. Clin J Pain. 2009;25(5):407.CrossRef Gold JI, Mahrer NE, Yee J, Palermo TM. Pain, fatigue and health-related quality of life in children and adolescents with chronic pain. Clin J Pain. 2009;25(5):407.CrossRef
18.
go back to reference The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
19.
go back to reference Brooks RG. 28 years of the EuroQol Group: an overview. EuroQol Working Paper Series; 2015. Brooks RG. 28 years of the EuroQol Group: an overview. EuroQol Working Paper Series; 2015.
20.
go back to reference Gudex C. The descriptive system of the EuroQOL instrument. In EQ-5D concepts and methods: a developmental history. Springer; 2005. p. 19–27. Gudex C. The descriptive system of the EuroQOL instrument. In EQ-5D concepts and methods: a developmental history. Springer; 2005. p. 19–27.
21.
go back to reference Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L. An exploratory study to test the impact on three “bolt-on” items to the EQ-5D. Value Health. 2015;18(1):52–60.CrossRef Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L. An exploratory study to test the impact on three “bolt-on” items to the EQ-5D. Value Health. 2015;18(1):52–60.CrossRef
22.
go back to reference Longworth L, Yang Y, Young T, Mulhern B, Hernandez Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1–224.CrossRef Longworth L, Yang Y, Young T, Mulhern B, Hernandez Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1–224.CrossRef
23.
go back to reference Shah K, Mulhern B, Longworth L, Janssen B. Important aspects of health not captured by EQ-5D: Views of the UK general public. Office of Health Economics; 2016. Shah K, Mulhern B, Longworth L, Janssen B. Important aspects of health not captured by EQ-5D: Views of the UK general public. Office of Health Economics; 2016.
24.
go back to reference Devlin NJ, Hansen P, Selai C. Understanding health state valuations: a qualitative analysis of respondents’ comments. Qual Life Res. 2004;13(7):1265–77.CrossRef Devlin NJ, Hansen P, Selai C. Understanding health state valuations: a qualitative analysis of respondents’ comments. Qual Life Res. 2004;13(7):1265–77.CrossRef
25.
go back to reference Efthymiadou O, Mossman J, Kanavos P. Health related quality of life aspects not captured by EQ-5D-5L: results from an international survey of patients. Health Policy. 2019;123(2):159–65.CrossRef Efthymiadou O, Mossman J, Kanavos P. Health related quality of life aspects not captured by EQ-5D-5L: results from an international survey of patients. Health Policy. 2019;123(2):159–65.CrossRef
26.
go back to reference van’t Leven M, Zielhuis GA, van der Meer JW, Verbeek AL, Bleijenberg G. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health. 2010;20(3):251–7.CrossRef van’t Leven M, Zielhuis GA, van der Meer JW, Verbeek AL, Bleijenberg G. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health. 2010;20(3):251–7.CrossRef
27.
go back to reference Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general practice. Ir J Med Sci. 2002;171(1):10.CrossRef Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general practice. Ir J Med Sci. 2002;171(1):10.CrossRef
28.
go back to reference Basu N, Yang X, Luben RN, Whibley D, Macfarlane GJ, Wareham NJ, et al. Fatigue is associated with excess mortality in the general population: results from the EPIC-Norfolk study. BMC Med. 2016;14(1):122.CrossRef Basu N, Yang X, Luben RN, Whibley D, Macfarlane GJ, Wareham NJ, et al. Fatigue is associated with excess mortality in the general population: results from the EPIC-Norfolk study. BMC Med. 2016;14(1):122.CrossRef
29.
go back to reference Janssen M, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–27.CrossRef Janssen M, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–27.CrossRef
30.
go back to reference Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–97.CrossRef Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–97.CrossRef
31.
go back to reference Voormolen DC, Cnossen MC, Polinder S, Gravesteijn BY, Von Steinbuechel N, Real RGL, et al. Prevalence of post-concussion-like symptoms in the general population in Italy, The Netherlands and the United Kingdom. Brain Inj. 2019;33:1–9.CrossRef Voormolen DC, Cnossen MC, Polinder S, Gravesteijn BY, Von Steinbuechel N, Real RGL, et al. Prevalence of post-concussion-like symptoms in the general population in Italy, The Netherlands and the United Kingdom. Brain Inj. 2019;33:1–9.CrossRef
32.
go back to reference UNESCO United Nations Educational S, Organization C. International standard classification of education, ISCED 1997. Advances in Cross-National Comparison: A European Working Book for Demographic and Socio-Economic Variables; 2003. p. 195–220. UNESCO United Nations Educational S, Organization C. International standard classification of education, ISCED 1997. Advances in Cross-National Comparison: A European Working Book for Demographic and Socio-Economic Variables; 2003. p. 195–220.
33.
go back to reference Versteegh MM, Vermeulen KM, Evers SM, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343–52.CrossRef Versteegh MM, Vermeulen KM, Evers SM, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343–52.CrossRef
34.
go back to reference Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.CrossRef Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.CrossRef
35.
go back to reference King N, Crawford S, Wenden F, Moss N, Wade D. The rivermead post concussion symptoms questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242(9):587–92.CrossRef King N, Crawford S, Wenden F, Moss N, Wade D. The rivermead post concussion symptoms questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242(9):587–92.CrossRef
36.
go back to reference De Smedt D, Clays E, Doyle F, Kotseva K, Prugger C, Pająk A, et al. Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. Int J Cardiol. 2013;167(5):2294–9.CrossRef De Smedt D, Clays E, Doyle F, Kotseva K, Prugger C, Pająk A, et al. Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. Int J Cardiol. 2013;167(5):2294–9.CrossRef
37.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. London: Routledge; 2013.CrossRef Cohen J. Statistical power analysis for the behavioral sciences. London: Routledge; 2013.CrossRef
38.
go back to reference Finch AP, Brazier JE, Mukuria C. Selecting bolt-on dimensions for the EQ-5D: examining their contribution to health-related quality of life. Value Health. 2019;22(1):50–61.CrossRef Finch AP, Brazier JE, Mukuria C. Selecting bolt-on dimensions for the EQ-5D: examining their contribution to health-related quality of life. Value Health. 2019;22(1):50–61.CrossRef
39.
go back to reference Perneger TV, Courvoisier DS. Exploration of health dimensions to be included in multi-attribute health-utility assessment. Int J Qual Health Care. 2011;23(1):52–9.CrossRef Perneger TV, Courvoisier DS. Exploration of health dimensions to be included in multi-attribute health-utility assessment. Int J Qual Health Care. 2011;23(1):52–9.CrossRef
40.
go back to reference Krabbe PF, Stouthard ME, Essink-Bot M-L, Bonsel GJ. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293–301.CrossRef Krabbe PF, Stouthard ME, Essink-Bot M-L, Bonsel GJ. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293–301.CrossRef
41.
go back to reference Buchholz I, Janssen MF, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645–61.CrossRef Buchholz I, Janssen MF, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645–61.CrossRef
Metadata
Title
The relation between EQ-5D and fatigue in a Dutch general population sample: an explorative study
Authors
I. Spronk
S. Polinder
G. J. Bonsel
M. F. Janssen
J. A. Haagsma
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Fatigue
Published in
Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-021-01771-3

Other articles of this Issue 1/2021

Health and Quality of Life Outcomes 1/2021 Go to the issue